Community Treatment Programs Take Up Buprenorphine
نویسندگان
چکیده
Clinicians have been working out ways to incorporate buprenorphine into their treatment models. Representatives of three addiction treatment programs - a Veterans Affairs methadone clinic, a group of outpatient mental health centers, and a nationwide organization of therapeutic communities - talk about their plans and experiences.
منابع مشابه
Stepping Into the Wide World
dential treatment that benefits both substance abusers and their children. While both authors share a focus on treating families, they do so from opposite poles of the research-practice spectrum, and bridging the distance is important to both. Fals-Stewart's intervention has performed well in studies over 20 years, but has yet to be widely adopted by community clinics. Jackson's program is high...
متن کاملBuprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.
The National Drug Abuse Treatment Clinical Trials Network (CTN), a collaborative federal research initiative that brings together universities and community-based treatment programs (CTPs), has conducted multiple clinical trials of buprenorphine for opioid dependence. Part of the CTN's mission is to promote the adoption of evidence-based treatment technologies. Drawing on a data collected durin...
متن کاملCommunity-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.
OBJECTIVE To document the development of unique opioid-dependence treatment in remote communities that combines First Nations healing strategies and substitution therapy with buprenorphine-naloxone. DESIGN Quantitative measurements of community wellness and response to community-based opioid-dependence treatment. SETTING Remote First Nations community in northwestern Ontario. PARTICIPANTS...
متن کاملState policy influence on the early diffusion of buprenorphine in community treatment programs
BACKGROUND Buprenorphine was approved for use in the treatment of opioid dependence in 2002, but its diffusion into everyday clinical practice in community-based treatment programs has been slow. This study examines the net impact of efforts by state agencies, including provision of Medicaid coverage, on program-level adoption of buprenorphine as of 2006. METHODS Interviews were conducted wit...
متن کاملBringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
In October 2002, the U.S. Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for Clinical Trials Network (CTN) sponsored two clinical trials assessing buprenorphine-naloxone for short-term opioid detoxification. These trials provid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 2 شماره
صفحات -
تاریخ انتشار 2004